β-Cell regeneration: a potential cure for Type 1 diabetes

Author： Kulis Jr Michael D Shuker Suzanne B

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.5, 2004-05, pp. : 599-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vildagliptin Induces &bgr;-Cell Neogenesis and Improves the Lipid Profile in a Later Phase of Type 1 Diabetes

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 1, 2015-01 ,pp. : 60-65

Bentham Science Publishers

Access to resources Recommend Favorite

What are the Potential Benefits of Clinical &bgr;-Cell Imaging in Diabetes Mellitus?

Current Pharmaceutical Design, Vol. 16, Iss. 14, 2010-05 ,pp. : 1547-1549

Bentham Science Publishers

Access to resources Recommend Favorite

Viral Infection - A Cure for Type 1 Diabetes?

Current Medicinal Chemistry, Vol. 14, Iss. 19, 2007-08 ,pp. : 2048-2052

Bentham Science Publishers

Access to resources Recommend Favorite

Can't beta dose of vildagliptin for β-cell function in type 2 diabetes

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Benefits of better β-cell function with anakinra in type 2 diabetes?

Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite